Ironwood Pharmaceuticals Inc IRWD released topline results from its pivotal Phase 3 STARS trial of once-weekly subcutaneous apraglutide in reducing parenteral...
Ironwood Pharmaceuticals Inc IRWD released topline results from its pivotal Phase 3 STARS trial of once-weekly subcutaneous apraglutide in reducing parenteral...